Amneal Pharmaceuticals, Inc. (AMRX:NASDAQ) closed at $21.23 on November 16, 2026, down 0.70% on the day. The stock trades 3.8% below its 52-week high of $22.07 and 86.4% above its 52-week low of $11.39. Over the past year, it gained 83.5%. Amneal Pharmaceuticals, Inc. is part of the Health Care sector.
In 252 trading sessions since November 14, 2025, AMRX closed higher on 128 days (51%). Its best day was September 16, 2026 (+8.59%) and its worst was November 2, 2026 (-4.97%). It never moved 10% or more in a single session.
Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals, and the Specialty segment is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies.
Find more stocks like AMRX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.